Martin Voegtli News
-
The next drug approval for Merck KGaA, Germany’s second-biggest drugmaker, probably won’t come until 2016, more than a decade after the blockbuster cancer treatment Erbitux reached the market.
-
Roche Holding AG, the Basel, Switzerland-based drugmaker that manufactures the world’s best- selling cancer treatment and reached a five-year high this week, has minted at least 12 Swiss and German billionaires. Seven have never appeared individually on an international wealth ranking.
-
Novartis AG’s Gilenya multiple sclerosis pill lost market share for the first time in January, following the deaths of some patients soon after taking the first pill available for the disease in the U.S.
-
Merck KGaA, the German maker of the cancer drug Erbitux, reported third-quarter profit that exceeded analyst estimates and increased the full-year sales forecast on higher demand for its medicines.
-
Illumina Inc. gained the most in almost a year after Swiss newspaper L’Agefi said Roche Holding AG may have agreed to buy the U.S. maker of DNA sequencing equipment at a price 48 percent higher than its original unsuccessful bid.
-
Novo Nordisk A/S’s once-a-day insulin medicine Tresiba carries a higher heart risk than other diabetes treatments, U.S. regulators said. Novo’s shares dropped.
-
Novartis AG backed off a prediction that a U.S. factory will resume making products such as the athlete’s foot gel Lamisil this year after shutting the facility in January because of manufacturing flaws.
-
Novartis AG will cut 1,960 jobs in the U.S. and take $1.22 billion of charges to prepare for lower sales of two blood-pressure drugs.
-
Roche Holding AG favors acquisitions of as much as $7 billion over spending cash on share buybacks, Chief Financial Officer Alan Hippe told Bloomberg Industries analysts at a meeting.
-
Roche Holding AG is abandoning a $6.7 billion bid for Illumina Inc. because investors are concerned the U.S. company’s gene-mapping technology may go the way of the 8-track or the floppy disc.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page